update on compounded semaglutide Important Update: Changes to Availability Compounded Tirzepatide Program: Results, Timeline

If you have Type 2 diabetes, you may already have coverage

J Cell Sci, 2009

CrossRef Artificial intelligence predicts sex-specific risk of metabolic dysfunction-associated steatotic liver disease Mohamad Jamalinia, Giovanni Targher, Amedeo Lonardo, Seyed Taghi Heydari, Kamran Bagheri Lankarani Biology of Sex Differences .2026;[Epub] CrossRef A carotenoid-rich functional tomato sauce (OsteoCol) reduces liver fat content in adults with metabolic dysfunction-associated steatotic liver disease: a randomized clinical trial Rosario Mare, Yvelise Ferro, Samantha Maurotti, Elisa Mazza, Alberto Castagna, Carmelo Pujia, Francesca Rita Noto, Angelo Galluccio, Angela Mirarchi, Giuseppe Andrea Giamp, Marta Moraca, Tiziana Montalcini, Arturo Pujia European Journal of Nutrition .2026;[Epub] CrossRef Association of the cholesterol-HDL-glucose index with prevalent metabolic dysfunction-associated steatotic liver disease and its incremental metabolic-hepatic assessment value: a hospital-based cross-sectional study Ziqian Song, Hao Sun, Cai Wang, Yuantao Qi, Yuan Liu Frontiers in Nutrition .2026;[Epub] CrossRef Apigenin attenuates hepatocyte senescence in metabolic dysfunction-associated steatotic liver disease by targeting the TGF- signaling pathway Lijun Cao, Yongna Zhao Cytotechnology .2026;[Epub] CrossRef A TyGUHR-based machine learning model for screening lean MAFLD: development and external validation Yansong Ji, Hui Zhang, Jingjing Xia, Guilian Chen, Hong Li BioMedical Engineering OnLine .2026;[Epub] CrossRef Intermittent fasting strategies for metabolic dysfunction-associated steatotic liver disease: A systematic review and frequentist network meta-analysis of randomized controlled trials Husam Abu Suilik, Ahmed Farid Gadelmawla, Mohamed Rifai, Moayad Alhawi, Abdellrahman Ashour, Hassan Abdalshafy, Omar Abdullah Bataineh, Hazem Rezq, Anas Bani Hani, Ismail Elkhattib, Mohamed Abuelazm Clinical Nutrition ESPEN .2026

While no global settlements have been announced, legal analysts estimate settlement ranges between $400,000 and $700,000 for serious gastroparesis cases

[DOI] [PMC free article] [PubMed] [Google Scholar] 161.Wo J.M., Ejskjaer N., Hellstrm P.M., Malik R.A., Pezzullo J.C., Shaughnessy L., Charlton P., Kosutic G., McCallum R.W